FEED Validator

for Atom and RSS and KML

Congratulations!

This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

line 39, column 0: description should not contain decoding attribute (8 occurrences) [help]
```
					<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" ...
```
line 42, column 0: content:encoded should not contain decoding attribute (38 occurrences) [help]
```
										<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img wi ...
```
line 69, column 0: description should not contain loading attribute (7 occurrences) [help]
```
					<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" ...
```
line 72, column 0: content:encoded should not contain loading attribute (15 occurrences) [help]
```
										<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img wi ...
```
line 3220, column 0: description should not contain sizes attribute (2 occurrences) [help]
```
					<description><![CDATA[<div style="margin-bottom:20px;"><img width="480" ...
```
line 3223, column 0: content:encoded should not contain sizes attribute (2 occurrences) [help]
```
										<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img wi ...
```

line 3229, column 0: content:encoded should not contain iframe tag [help]

<p title="Introducing Qiskit SDK v1.0"><iframe loading="lazy" frameborder="0 ...

line 3296, column 0: content:encoded should not contain aria-level attribute (4 occurrences) [help]
```
The repatriation agreement is the result of significant consultations and ...
```
line 3296, column 0: content:encoded should not contain role attribute (4 occurrences) [help]
```
The repatriation agreement is the result of significant consultations and ...
```
line 3296, column 0: style attribute contains potentially dangerous content: margin-block-start (16 occurrences) [help]
```
The repatriation agreement is the result of significant consultations and ...
```

Source: https://bubblear.com/feed/

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
xmlns:media="http://search.yahoo.com/mrss/" >
<channel>
<title>The Bubble</title>
<atom:link href="https://bubblear.com/feed/" rel="self" type="application/rss+xml" />
<link>https://bubblear.com</link>
<description>News | USA | Entertainment | Lifestyle | Health | Tech | Sports | Money</description>
<lastBuildDate>Thu, 16 May 2024 02:28:00 +0000</lastBuildDate>
<language>en-US</language>
<sy:updatePeriod>
hourly </sy:updatePeriod>
<sy:updateFrequency>
1 </sy:updateFrequency>
<generator>https://wordpress.org/?v=6.5.3</generator>
<image>
<url>https://bubblear.com/wp-content/uploads/2023/02/cropped-bubblear-logo-32x32.png</url>
<title>The Bubble</title>
<link>https://bubblear.com</link>
<width>32</width>
<height>32</height>
</image>
<item>
<title>DAISO NEW STORE OPENING IN FORT WORTH, TEXAS</title>
<link>https://bubblear.com/daiso-new-store-opening-in-fort-worth-texas/9053/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Thu, 16 May 2024 02:28:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/daiso-new-store-opening-in-fort-worth-texas/9053/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="26" src="https://bubblear.com/wp-content/uploads/2024/05/daiso-new-store-opening-in-fort-worth-texas.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" /></div>FORT WORTH, Texas, May 15, 2024 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Camp Bowie in Fort Worth, Texas on June 1st. “We are thrilled to open our store at Camp Bowie,” said Jack Williams, Chief Retail Operations […]
The post <a rel="nofollow" href="https://bubblear.com/daiso-new-store-opening-in-fort-worth-texas/9053/">DAISO NEW STORE OPENING IN FORT WORTH, TEXAS</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="26" src="https://bubblear.com/wp-content/uploads/2024/05/daiso-new-store-opening-in-fort-worth-texas.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" /></div>
FORT WORTH, Texas, May 15, 2024 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Camp Bowie in Fort Worth, Texas on June 1st. “We are thrilled to open our store at Camp Bowie,” said Jack Williams, Chief Retail Operations Officer for Daiso USA. “This achievement reflects the dedication and support of our customers who have embraced Daiso’s unique concept and diverse product range. We are excited to provide an exceptional shopping experience to the vibrant Fort Worth community and look forward to serving our customers with the utmost care and dedication.”
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Discover Daiso! (PRNewsfoto/Daiso USA)" src="https://mma.prnewswire.com/media/2070260/Daiso_USA___Logo.jpg" title="Discover Daiso! (PRNewsfoto/Daiso USA)"></img> 
</div>
The new Daiso store at Camp Bowie encompasses 9,824 square feet and promises to be a haven for shoppers seeking quality merchandise at affordable prices. With its extensive range of products spanning various categories, including Japanese inspired home decor, stationery, food, and more, Daiso has become synonymous with accessible and innovative offerings. John Clarke, Chief Development Officer for Daiso USA says, “Fort Worth based Daiso customers have shown us through our online business and social media their desire for us to have more stores within the state, influencing our immediate growth strategy in this region. We currently operate 126 units in 7 states with more states opening in 2024″.
On both Saturday, June 1st and Sunday, June 2nd, the first 100 customers to shop at the Camp Bowie location and make a minimum purchase of $30 will receive an exclusive goodie bag. These special offerings are Daiso’s way of expressing gratitude to its loyal customers and welcoming new shoppers to the Daiso community.
Daiso invites customers to join in the celebration. The Daiso, at 3501 Bernie Anderson, is open Monday through Saturday from 9 a.m to 9 p.m and Sunday from 10 a.m to 8 p.m.
About Daiso: Daiso is a global retail chain founded in Japan, known for its vast array of unique and affordable products across various categories such as household goods, stationery, beauty, and more. Daiso entered the US market in 2005 and continues to expand its global footprint while maintaining its commitment to quality, innovation, and customer satisfaction. The Daiso US headquarters is located in Anaheim, CA.
<img decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=LA16097&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/daiso-new-store-opening-in-fort-worth-texas-302147107.html
SOURCE Daiso USA
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA16097&Transmission_Id=202405152228PR_NEWS_USPR_____LA16097&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/daiso-new-store-opening-in-fort-worth-texas/9053/">DAISO NEW STORE OPENING IN FORT WORTH, TEXAS</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>Fuel Cells Market for Automotive Industry Market size is set to grow by USD 4382.26 mn from 2023-2027, increased demand for efficient and cleaner fuel to boost the market growth, Technavio</title>
<link>https://bubblear.com/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027-increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio/9055/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Thu, 16 May 2024 02:04:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027-increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio/9055/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="81" src="https://bubblear.com/wp-content/uploads/2024/05/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027-increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>NEW YORK, May 15, 2024 /PRNewswire/ — The global fuel cells market for automotive industry size is estimated to grow by USD 4382.26 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of almost 26.7% during the forecast period. For more insights on the forecast market size and historic data (2017 […]
The post <a rel="nofollow" href="https://bubblear.com/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027-increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio/9055/">Fuel Cells Market for Automotive Industry Market size is set to grow by USD 4382.26 mn from 2023-2027, increased demand for efficient and cleaner fuel to boost the market growth, Technavio</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="81" src="https://bubblear.com/wp-content/uploads/2024/05/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027-increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
NEW YORK, May 15, 2024 /PRNewswire/ — The global fuel cells market for automotive industry size is estimated to grow by USD 4382.26 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of almost 26.7% during the forecast period.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Technavio has announced its latest market research report titled Global Fuel Cells Market for Automotive Industry 2023-2027" src="https://mma.prnewswire.com/media/2413543/Technavio_Fuel_Cells_Market_for_Automotive_Industry_2023_2027.jpg" title="Technavio has announced its latest market research report titled Global Fuel Cells Market for Automotive Industry 2023-2027"></img> 
</div>
For more insights on the forecast market size and historic data (2017 – 2021) – Download Free sample report in a minutes
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prnpr2 prnpl8 prnvam prntal prncbts prnbrbrs prnbbbs prnbsbls" colspan="1" rowspan="1">
Forecast period
</td>
<td class="prnpr2 prnpl8 prnvam prntal prncbts prnbrbrs prnbbbs prnsblb1" colspan="1" rowspan="1">
2023-2027
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Base Year
</td>
<td class="prngen5" colspan="1" rowspan="1">
2022
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Historic Data
</td>
<td class="prngen5" colspan="1" rowspan="1">
2017 – 2021
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Segment Covered
</td>
<td class="prngen5" colspan="1" rowspan="1">
Fuel Type (Hydrogen and Methanol), Application (Light-duty vehicles, Heavy-duty vehicles, and Others), and Geography (APAC, North America, Europe, South America, and Middle East and Africa)
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Region Covered
</td>
<td class="prngen5" colspan="1" rowspan="1">
APAC, North America, Europe, South America, and Middle East and Africa
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Key companies profiled
</td>
<td class="prngen5" colspan="1" rowspan="1">
Acumentrics Inc, Ballard Power Systems Inc., BorgWarner Inc., Ceres Power Holdings plc, Cummins Inc., Daimler AG, ElringKlinger AG, Hyster Yale Materials Handling Inc., Hyundai Motor Co., Intelligent Energy Ltd., ITM Power plc, Nedstack Fuel Cell Technology BV, Nel ASA, PRAGMA INDUSTRIES, Proton Motor Fuel Cell GmbH, The Symbio SAS, TW Horizon Fuel Cell Technologies, Valmet Automotive Group, W. L. Gore and Associates Inc., and PowerCell Sweden AB
</td>
</tr>
</table>
</div>
Key Market Trends Fueling Growth
<ul type="disc">
<li>Fuel cells, a key technology in the automotive industry, have experienced significant cost reductions due to advancements in manufacturing techniques and the decrease in platinum usage.</li>
<li>Since 2008, costs have dropped by up to 30%. In 2014, fuel cells were produced at approximately USD280/kW. With increased production volume and advanced resources, costs are projected to reach around USD55/kW. Furthermore, the cost of producing hydrogen from natural gas is improving, leading to expectations of a further decline to USD30–USD40 per kW by 2020.</li>
<li>Hydrogen-based fuel, batteries, and clean hydrogen hubs are essential components in reducing greenhouse gas emissions in the transportation sector.</li>
<li>Fuel cells offer an environment-friendly alternative to traditional hydrocarbon-based systems in vehicles and stationary applications.</li>
<li>Small-scale and large-scale fuel cells, including those in fuel cell vehicles and tri-gen systems, contribute to the reduction of vehicle and greenhouse gas emissions.</li>
<li>Electric vehicles, an integral part of the adoption of alternative energy sources, are expected to benefit from these cost reductions. High fuel prices and purchase prices have hindered the widespread adoption of fuel cells, but the declining costs may change this trend.</li>
<li>Garbage trucks and hydrogen refueling stations are among the industries that can benefit from the environmental and cost advantages of fuel cell technology.</li>
</ul>
Market Challenges
<ul type="disc">
<li>The fuel cell market for the automotive industry faces significant challenges due to the limited availability of hydrogen filling stations. In 2020, there were approximately 458 hydrogen filling stations worldwide, significantly fewer than the 7.3 million chargers for electric vehicles (EVs) in residences and workplaces. Fuel cells offer advantages such as high efficiency, zero emissions, and quick refueling. They use proton exchange membrane (PEM) technology, which generates water as a byproduct. Hydrogen storage and transportation, as well as cell design and component materials, are crucial considerations for improving fuel cell efficiency, safety, and durability. Applications include utilities, military and defense, hospitals, hotels, shopping centers, office buildings, and sports centers. Renewable energy integration and incentives are essential for fuel cell adoption. Companies like Bloom Energy are pioneering advancements in residential and data center fuel cells.</li>
</ul>
Research report provides comprehensive data on impact of trend, driver and challenges – Buy Report
Segment Overview
This fuel cells market for automotive industry market report extensively covers market segmentation by
<ol type="1">
<li>Fuel Type</li>
<ul type="circle">
<li>1.1 Hydrogen</li>
<li>1.2 Methanol</li>
</ul>
<li>Application</li>
<ul type="circle">
<li>2.1 Light-duty vehicles</li>
<li>2.2 Heavy-duty vehicles</li>
<li>2.3 Others</li>
</ul>
<li>Geography</li>
<ul type="circle">
<li>3.1 APAC</li>
<li>3.2 North America</li>
<li>3.3 Europe</li>
<li>3.4 South America</li>
<li>3.5 Middle East and Africa</li>
</ul>
</ol>
1.1 Hydrogen- The hydrogen fuel cell market in the automotive industry undergoes segmentation based on fuel type. Hydrogen storage is a crucial factor in this segmentation, with considerations given to weight, volume, and efficiency. Safety, cost, and durability are additional key factors. In the context of data centers, PEM fuel cells are prominent due to their high efficiency and water generation capabilities. Balance of water and proton conductivity, activation potential, flooding, and drying out are essential aspects of PEM fuel cell design. Water content and polymer membrane quality significantly impact reactant diffusion and catalyst sites’ performance. Flooding of electrodes, gas diffusion backings, gas channels, and current density are also critical design considerations. Temperature, reactant flow rates, pressures, and humidification are essential operating parameters. Cell design and component materials are crucial for ensuring water management and overall system efficiency. Notable applications of hydrogen fuel cells include data centers, utilities, military and defense, hospitals, hotels, shopping center malls, office buildings, and sports centers. Fuel cell adoption is influenced by incentives and the increasing use of renewable energy.
For more information on market segmentation with geographical analysis including forecast (2023-2027) and historic data (2017 – 2021) – Download a Sample Report
Research Analysis
The fuel cells market for the automotive industry is experiencing significant growth due to the increasing adoption of fuel cell vehicles (FCVs) as an alternative to traditional internal combustion engine vehicles. FCVs produce only water as a byproduct, making them an attractive option for reducing vehicle emissions, including greenhouse gases. Hydrogen-based fuel cells, specifically, offer a clean energy source for transportation, emitting only water and heat. The global energy review highlights the potential of hydrogen as a viable alternative energy source for the transportation sector. Fuel cell technology, including Solid Oxide Fuel Cells (SOFCs), is advancing with innovations in the stack design, balance of plant components such as air compressors and power conditioners, and the integration of tri-gen systems. Electric vehicles (EVs) with fuel cell range extenders are also gaining traction, offering the benefits of both electric motor technology and hydrogen-based fuel cells. The future of clean and sustainable transportation lies in the continued development and adoption of these technologies.
Market Research Overview
The Fuel Cells market holds significant potential in the Automotive Industry due to the increasing demand for sustainable and efficient energy solutions. Fuel cells convert chemical energy into electrical energy through a reaction between hydrogen and oxygen, producing only water as a byproduct. This makes fuel cells an attractive alternative to traditional internal combustion engines. The technology is currently being adopted in various applications, including buses, trucks, and passenger cars. The global market for fuel cells in the automotive sector is expected to grow steadily, driven by government initiatives to reduce emissions and the increasing availability of hydrogen refueling stations. The future of fuel cells in the automotive industry looks promising, with advancements in technology leading to improved efficiency and cost-effectiveness.
Table of Contents:
1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation
<ul type="disc">
<li>Fuel Type</li>
<ul type="circle">
<li>Hydrogen</li>
<li>Methanol</li>
</ul>
<li>Application</li>
<ul type="circle">
<li>Light-duty Vehicles</li>
<li>Heavy-duty Vehicles</li>
<li>Others</li>
</ul>
<li>Geography</li>
<ul type="circle">
<li>APAC</li>
<li>North America</li>
<li>Europe</li>
<li>South America</li>
<li>Middle East And Africa</li>
</ul>
</ul>
7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: media@technavio.com Website: www.technavio.com/
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <img decoding="async" alt="Global Fuel Cells Market for Automotive Industry 2023-2027" src="https://mma.prnewswire.com/media/2413544/Technavio_Logo_Logo.jpg" title="Global Fuel Cells Market for Automotive Industry 2023-2027"></img> 
</div>
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=CG15177&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027–increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio-302146318.html
SOURCE Technavio
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG15177&Transmission_Id=202405152204PR_NEWS_USPR_____CG15177&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/fuel-cells-market-for-automotive-industry-market-size-is-set-to-grow-by-usd-4382-26-mn-from-2023-2027-increased-demand-for-efficient-and-cleaner-fuel-to-boost-the-market-growth-technavio/9055/">Fuel Cells Market for Automotive Industry Market size is set to grow by USD 4382.26 mn from 2023-2027, increased demand for efficient and cleaner fuel to boost the market growth, Technavio</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT</title>
<link>https://bubblear.com/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-alt/9057/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Thu, 16 May 2024 02:01:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-alt/9057/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="53" src="https://bubblear.com/wp-content/uploads/2024/05/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-alt.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>NEW YORK, May 15, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class Period”), of the important July 5, 2024 lead plaintiff deadline. SO WHAT: If you purchased Altimmune securities during […]
The post <a rel="nofollow" href="https://bubblear.com/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-alt/9057/">ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="53" src="https://bubblear.com/wp-content/uploads/2024/05/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-alt.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
NEW YORK, May 15, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class Period”), of the important July 5, 2024 lead plaintiff deadline.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Rosen Law Firm, P.A. Logo" src="https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg" title="Rosen Law Firm, P.A. Logo"></img> 
</div>
SO WHAT: If you purchased Altimmune securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Altimmune class action, go to https://rosenlegal.com/submit-form/?case_id=22535 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 5, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Altimmune overstated the potential for its lead product candidate, pemvidutide, a glucagon-like peptide-1 (“GLP-1”), to stand out from competing GLP-1 agonists based on the drug’s efficacy and tolerability results observed in evaluating pemvidutide for the treatment of obesity (the “MOMENTUM Trial”); (2) accordingly, the MOMENTUM trial results were less significant to pemvidutide’s clinical, commercial, and competitive prospects than defendants had led investors to believe; (3) as a result of all the foregoing, defendants had overstated Altimmune’s prospects for finding a strategic partner to develop pemvidutide; and (4) as a result, Altimmune’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Altimmune class action, go to https://rosenlegal.com/submit-form/?case_id=22535 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=DC16031&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action–alt-302147004.html
SOURCE THE ROSEN LAW FIRM, P. A.
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC16031&Transmission_Id=202405152201PR_NEWS_USPR_____DC16031&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/rosen-global-investor-counsel-encourages-altimmune-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-alt/9057/">ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>$725M Verdict Against ExxonMobil in Landmark Benzene Cancer Case</title>
<link>https://bubblear.com/725m-verdict-against-exxonmobil-in-landmark-benzene-cancer-case/9044/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 20:07:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/725m-verdict-against-exxonmobil-in-landmark-benzene-cancer-case/9044/</guid>
<description><![CDATA[Locks Law Firm: Philadelphia jury finds benzene in gasoline caused leukemia PHILADELPHIA, May 15, 2024 /PRNewswire/ — Andrew DuPont of Locks Law Firm, obtained a verdict of $725.5M against ExxonMobil on behalf of Paul Gill and his wife Diane Gill in a benzene case in the Philadelphia Court of Common Pleas. Paul Gill was exposed to […]
The post <a rel="nofollow" href="https://bubblear.com/725m-verdict-against-exxonmobil-in-landmark-benzene-cancer-case/9044/">$725M Verdict Against ExxonMobil in Landmark Benzene Cancer Case</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[
Locks Law Firm: Philadelphia jury finds benzene in gasoline caused leukemia 
PHILADELPHIA, May 15, 2024 /PRNewswire/ — Andrew DuPont of Locks Law Firm, obtained a verdict of $725.5M against ExxonMobil on behalf of Paul Gill and his wife Diane Gill in a benzene case in the Philadelphia Court of Common Pleas.
Paul Gill was exposed to benzene contained in Mobil Oil gasoline when he worked as a mechanic and gasoline station attendant between 1974 and 1979. As a result of his exposure, he developed Acute Myeloid Leukemia. Over 7 days, the jury heard evidence of Mr. Gill’s exposures to benzene from gasoline, Mobil Oil’s failure to warn him, and the significant harm that he and his wife Diane Gill sustained as the result of his developing both Acute Myeloid Leukemia and Colon Cancer that metastasized to his liver. The jury also heard compelling admissions from an ExxonMobil representative that the company knew of the hazards of benzene in gasoline two decades prior to Mr. Gill’s exposures yet did not disclose this information or take action to protect him.
“This verdict not only holds ExxonMobil accountable for Mr. Gill’s injuries, but brings to light the cancer hazard of exposure to benzene in gasoline,” said Andrew DuPont, partner with Locks Law Firm. “These cases are hard fought. We appreciate that the jury paid close attention to the evidence and applied what they heard to the law that they were instructed on by the Court.”
The case is Paul Gill and Diane Gill v. ExxonMobil et al., Case ID 200501803, in Pennsylvania’s First Judicial District.
Locks Law Firm’s benzene team consistently obtains great results in benzene cases. DuPont, the leader of this team, has over 20 years of experience litigating benzene cases, making him one of the preeminent lawyers on the subject matter, with over 50 settlements. Last week’s verdict was the largest ever in a benzene case.
In addition to Mr. DuPont, Mr. Gill was represented by Waters Kraus Paul & Siegel partners Patrick Wigle and Rajeev Mittal.
About Locks Law Firm
With offices in Philadelphia, New York City and Cherry Hill, New Jersey, Locks Law Firm is known for protecting the rights of consumers throughout the country, as well as individuals and families who have suffered injuries or death as a result of the recklessness or negligence of another party including cases involving benzene, dangerous pharmaceuticals, toxic chemicals and asbestos. Attorneys at the Locks Law Firm practice with the highest level of professional integrity and have extensive courtroom experience. For additional information, visit www.lockslaw.com or call 215-893-0100.
Janet Lewis jlewis@lockslaw.com 215.893.3400 Cell: 267.994.5322
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=PH15780&sd=2024-05-15" title="Cision" width="12"></img> View original content:https://www.prnewswire.com/news-releases/725m-verdict-against-exxonmobil-in-landmark-benzene-cancer-case-302146886.html
SOURCE Locks Law Firm
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH15780&Transmission_Id=202405151606PR_NEWS_USPR_____PH15780&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/725m-verdict-against-exxonmobil-in-landmark-benzene-cancer-case/9044/">$725M Verdict Against ExxonMobil in Landmark Benzene Cancer Case</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>Movano Health Reports Q1 2024 Financial Results and Provides Business Update</title>
<link>https://bubblear.com/movano-health-reports-q1-2024-financial-results-and-provides-business-update/9047/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 20:05:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/movano-health-reports-q1-2024-financial-results-and-provides-business-update/9047/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="33" src="https://bubblear.com/wp-content/uploads/2024/05/movano-health-reports-q1-2024-financial-results-and-provides-business-update.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance processPlans launch of Evie Med and focuses on B2B opportunitiesPlans arterial blood pressure study for JuneConference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., May 15, 2024 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter […]
The post <a rel="nofollow" href="https://bubblear.com/movano-health-reports-q1-2024-financial-results-and-provides-business-update/9047/">Movano Health Reports Q1 2024 Financial Results and Provides Business Update</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="33" src="https://bubblear.com/wp-content/uploads/2024/05/movano-health-reports-q1-2024-financial-results-and-provides-business-update.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT/ 5:00 PM ET Today
PLEASANTON, Calif., May 15, 2024 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter 2024 results and provided a business update.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Movano Health + Evie logo (PRNewsfoto/Movano)" src="https://mma.prnewswire.com/media/2143427/Movano_Evie_Logo.jpg" title="Movano Health + Evie logo (PRNewsfoto/Movano)"></img> 
</div>
Following the successful close of its recent $24 million private placement that included a seed investment from a tier 1 multi-billion dollar medical device company, Movano Health has been focused on three key initiatives:
<ul type="disc">
<li>Enhancing the Evie product experience, improving its operations processes, and bolstering customer service in preparation to begin taking direct-to-consumer (D2C) orders again.</li>
<li>Securing FDA 510(k) clearance for its pulse oximeter, the Evie Med Ring, and pursuing key business-to-business (B2B) partnerships. The Company continues to expect a decision regarding its 510(k) clearance in July 2024.</li>
<li>Advancing cuffless blood pressure clinical studies with Movano Health’s System-on-a-Chip (SoC).</li>
</ul>
“We learned a great deal from the recent D2C launch of the Evie Ring, and a key goal for 2024 is to continue to improve the consumer experience across product, delivery and customer service in order to maximize our sales potential,” said John Mastrototaro, CEO and President of Movano Health. “Additionally, we are focused on obtaining the FDA clearances necessary to launch Evie Med, the cornerstone of our enterprise initiative.” 
Recent Operating Highlights and Milestones 
<ul type="disc">
<li>The Company successfully shipped its first commercial ring on January 22, 2024. Demand was extremely high, and orders are currently paused. The Company is working on improvements across all business verticals in preparation to begin taking orders again.</li>
<li>On April 22, 2024, Movano Health successfully submitted updated pivotal clinical trial results as well as proof of enhanced medical device usability to the U.S. Food and Drug Administration (FDA) as part of its 510(k) filing for the Company’s first commercial medical device, the Evie Med Ring pulse oximeter. During the trial, each subject wore four Evie Med Rings. The four Evie Med Rings achieved a pooled root mean square error (RMSE) of 2.46% in over 800 paired samples, which was once again well below the FDA guidance of 3.5% for SpO2. Additionally, the Evie Med Ring’s accuracy exceeded that of the two commercially available, hospital-grade reference pulse oximeters in the study. The Company continues to expect a decision on its 510(k) clearance from the FDA in July 2024.</li>
<li>Following positive results from a blood pressure clinical study conducted in October 2023, the Company has been making enhancements to the prototype used in that study and is planning another blood pressure study to take place this June, which will be the first study conducted with an arterial line, the precursor to an FDA pivotal study. Unlike a cuff which provides only one blood pressure value, an arterial line will provide continuous data on patients. In addition, Movano Health is also evaluating AI-based individual calibration methods to further enhance the future performance of the platform.</li>
</ul>
First Quarter 2024 and Recent Financial Highlights
<ul type="disc">
<li>On April 4, 2024, Movano Health closed a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the Company’s common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that included a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company’s management team and board of directors. Movano Health intends to use the net proceeds from the financing for working capital and general corporate purposes.</li>
<li>In Q1 2024, Movano Health generated $852,000 in revenue. The Company shipped 5,305 Evie Rings in the period.</li>
<li>The Company reported an operating loss of $5.8 million in Q1 2024, compared to an operating loss of $7.2 million in Q1 2023.</li>
<li>Total cash and cash equivalents at March 31, 2024 were $2.1 million.</li>
</ul>
Conference Call
Management will host a conference call and live audio webcast to discuss these results and provide a business update today at 2:00 pm PT/5:00 pm ET.
Attendees can access the live webcast here or on the investors section of Movano Health’s website at https://ir.movano.com. The conference call can be accessed by dialing 1-877-407-0989 (domestic), or 1 201-389-0921 (international). Attendees can also use the Call Me Link in which they will be dialed in to the conference call instantly on the number provided with no hold time. An archived webcast will be available on Movano Health’s website approximately one hour after the completion of the event and for two years thereafter.
About Movano Health 
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health’s devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and uniquely translating it into personalized and intelligent insights.
Movano Health’s proprietary technologies and wearable medical device solutions will soon enable the use of data as a tool to proactively monitor and manage health outcomes across a number of patient populations that exist in healthcare. For more information on Movano Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding plans with respect to the commercial launches of the Evie Ring and Evie Med; planned cost-cutting initiatives; anticipated FDA clearance decisions with respect to our products; expected future operating results; product development and features, product releases, clinical trials and regulatory initiatives; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption “Risk Factors.” Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
 
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td align="center" class="prngen2" colspan="5" nowrap="nowrap" rowspan="1">
Movano Inc.
</td>
</tr>
<tr>
<td align="center" class="prngen2" colspan="5" nowrap="nowrap" rowspan="1">
CONDENSED CONSOLIDATED BALANCE SHEETS
</td>
</tr>
<tr>
<td align="center" class="prngen2" colspan="5" nowrap="nowrap" rowspan="1">
(In thousands)
</td>
</tr>
<tr>
<td align="center" class="prngen2" colspan="5" nowrap="nowrap" rowspan="1">
(Unaudited)
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen4" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td align="center" class="prngen5" colspan="1" nowrap="nowrap" rowspan="1">
March 31,
</td>
<td class="prngen6" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td align="center" class="prngen5" colspan="1" nowrap="nowrap" rowspan="1">
December 31,
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen7" colspan="1" nowrap="nowrap" rowspan="1">
2024
</td>
<td class="prngen6" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen7" colspan="1" nowrap="nowrap" rowspan="1">
2023
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
ASSETS
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Current assets:
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Cash and cash equivalents
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
$ 2,145
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
$ 6,118
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Payroll tax credit, current portion
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
514
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
450
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Vendor deposits
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
396
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
399
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Inventory
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
1,064
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
1,114
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Prepaid expenses and other current assets
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
326
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
442
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1">
Total current assets
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen10" colspan="1" nowrap="nowrap" rowspan="1">
4,445
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen10" colspan="1" nowrap="nowrap" rowspan="1">
8,523
</td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Property and equipment, net
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
299
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
342
</td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Payroll tax credit, noncurrent portion
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
64
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
169
</td>
</tr>
<tr>
<td class="prnpr2 prnpl2 prnvab prntal prnsbtb1 prnrbrb1 prnsbbb1 prnsblb1" colspan="1" nowrap="nowrap" rowspan="1">
Other assets
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
327
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
387
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1">
Total assets
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen12" colspan="1" nowrap="nowrap" rowspan="1">
$ 5,135
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen12" colspan="1" nowrap="nowrap" rowspan="1">
$ 9,421
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Current liabilities:
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Accounts payable
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
$ 3,977
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
$ 3,118
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Deferred revenue
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
251
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
1,252
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Other current liabilities
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
2,341
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
1,529
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1">
Total current liabilities
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen10" colspan="1" nowrap="nowrap" rowspan="1">
6,569
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen10" colspan="1" nowrap="nowrap" rowspan="1">
5,899
</td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Noncurrent liabilities:
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Early exercised stock option liability
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
11
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
23
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Other noncurrent liabilities
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
33
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
50
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1">
Total noncurrent liabilities
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
44
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
73
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1">
Total liabilities
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
6,613
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
5,972
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Stockholders’ equity (deficit):
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Common stock
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
6
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
6
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Additional paid-in capital
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
128,616
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
127,823
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Accumulated deficit
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen15" colspan="1" nowrap="nowrap" rowspan="1">
(130,100)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen15" colspan="1" nowrap="nowrap" rowspan="1">
(124,380)
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Total stockholders’ equity (deficit)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prnpr2 prnpl2 prnvab prntar prncbts prnrbrb1 prnbbbs prnsblb1" colspan="1" nowrap="nowrap" rowspan="1">
(1,478)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
3,449
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1">
Total liabilities and stockholders’ equity (deficit)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
$ 5,135
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
$ 9,421
</td>
</tr>
</table>
</div>
 
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td align="center" class="prngen2" colspan="7" nowrap="nowrap" rowspan="1">
Movano Inc.
</td>
</tr>
<tr>
<td align="center" class="prngen2" colspan="7" nowrap="nowrap" rowspan="1">
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
</td>
</tr>
<tr>
<td align="center" class="prngen2" colspan="7" nowrap="nowrap" rowspan="1">
(In thousands, except share and per share data)
</td>
</tr>
<tr>
<td align="center" class="prngen2" colspan="7" nowrap="nowrap" rowspan="1">
(Unaudited)
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen5" colspan="3" nowrap="nowrap" rowspan="1">
Three Months Ended March 31,
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen7" colspan="1" nowrap="nowrap" rowspan="1">
2024
</td>
<td class="prngen6" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen7" colspan="1" nowrap="nowrap" rowspan="1">
2023
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Revenue
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
$ 852
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
$ —
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
COSTS AND EXPENSES:
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Cost of revenue
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
1,215
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
—
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Research and development
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
2,887
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
3,894
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Sales, general and administrative
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
2,504
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
3,309
</td>
</tr>
<tr>
<td class="prnpr2 prnvab prntal prnsbtb1 prnrbrb1 prnsbbb1 prnsblb1" colspan="1" nowrap="nowrap" rowspan="1">
 Total costs and expenses
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
6,606
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
7,203
</td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Loss from operations
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen19" colspan="1" nowrap="nowrap" rowspan="1">
(5,754)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen19" colspan="1" nowrap="nowrap" rowspan="1">
(7,203)
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Other income (expense), net:
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Interest and other income, net
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
34
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
107
</td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
 Other income (expense), net
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
34
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1">
107
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Net loss and total comprehensive loss
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen20" colspan="1" nowrap="nowrap" rowspan="1">
$ (5,720)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen20" colspan="1" nowrap="nowrap" rowspan="1">
$ (7,096)
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Net loss per share, basic and diluted
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
$ (0.10)
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
$ (0.19)
</td>
</tr>
<tr>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen2" colspan="1" nowrap="nowrap" rowspan="1">
Weighted average shares used in computing net loss per share, basic and diluted
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
56,023,273
</td>
<td class="prngen3" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
37,541,070
</td>
</tr>
</table>
</div>
 
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=SF15751&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-health-reports-q1-2024-financial-results-and-provides-business-update-302146862.html
SOURCE Movano
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=SF15751&Transmission_Id=202405151605PR_NEWS_USPR_____SF15751&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/movano-health-reports-q1-2024-financial-results-and-provides-business-update/9047/">Movano Health Reports Q1 2024 Financial Results and Provides Business Update</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>Schwazze Announces First Quarter 2024 Financial Results</title>
<link>https://bubblear.com/schwazze-announces-first-quarter-2024-financial-results/9045/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 20:05:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/schwazze-announces-first-quarter-2024-financial-results/9045/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="49" src="https://bubblear.com/wp-content/uploads/2024/05/schwazze-announces-first-quarter-2024-financial-results.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, May 15, 2024 /PRNewswire/ – Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024. “We delivered another period of revenue growth in […]
The post <a rel="nofollow" href="https://bubblear.com/schwazze-announces-first-quarter-2024-financial-results/9045/">Schwazze Announces First Quarter 2024 Financial Results</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="49" src="https://bubblear.com/wp-content/uploads/2024/05/schwazze-announces-first-quarter-2024-financial-results.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time
DENVER, May 15, 2024 /PRNewswire/ – Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Schwazze Logo (CNW Group/Schwazze)" src="https://mma.prnewswire.com/media/2413984/Schwazze_Schwazze_Announces_First_Quarter_2024_Financial_Results.jpg" title="Schwazze Logo (CNW Group/Schwazze)"></img> 
</div>
“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”
“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”
“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”
“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”
First Quarter 2024 Financial Summary
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prnpr2 prnpl2 prnvab prncbts prnbrbrs prnbbbs prnbsbls" colspan="1" rowspan="1">
$ in Thousands USD
</td>
<td class="prngen3" colspan="1" rowspan="1">
Q1 2024
</td>
<td class="prngen3" colspan="1" rowspan="1">
Q4 2023
</td>
<td class="prngen3" colspan="1" rowspan="1">
Q1 2023
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Total Revenue
</td>
<td class="prngen5" colspan="1" rowspan="1">
$41,601
</td>
<td class="prngen5" colspan="1" rowspan="1">
$43,325
</td>
<td class="prngen5" colspan="1" rowspan="1">
$40,001
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Gross Profit
</td>
<td class="prngen5" colspan="1" rowspan="1">
$17,934
</td>
<td class="prnpr2 prnpl2 prnvab prnsbtb1 prnbrbrs prnbbbs prnsblb1" colspan="1" rowspan="1">
$7,034[1] 
</td>
<td class="prngen5" colspan="1" rowspan="1">
$21,849
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Operating Expenses
</td>
<td class="prngen5" colspan="1" rowspan="1">
$20,643
</td>
<td class="prngen5" colspan="1" rowspan="1">
$23,276
</td>
<td class="prngen5" colspan="1" rowspan="1">
$16,199
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Income (Loss) from Operations
</td>
<td class="prngen7" colspan="1" rowspan="1">
$(2,709)
</td>
<td class="prngen7" colspan="1" rowspan="1">
$(16,242)
</td>
<td class="prngen5" colspan="1" rowspan="1">
$5,650
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Adjusted EBITDA[2]
</td>
<td class="prngen5" colspan="1" rowspan="1">
$7,341
</td>
<td class="prngen5" colspan="1" rowspan="1">
$10,953
</td>
<td class="prngen5" colspan="1" rowspan="1">
$14,525
</td>
</tr>
<tr>
<td class="prngen4" colspan="1" rowspan="1">
Operating Cash Flow
</td>
<td class="prngen7" colspan="1" rowspan="1">
$(3,700)
</td>
<td class="prngen5" colspan="1" rowspan="1">
$3,452
</td>
<td class="prngen7" colspan="1" rowspan="1">
$(880)
</td>
</tr>
</table>
</div>
Recent Highlights
<ul type="disc">
<li>Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.</li>
<li>Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.</li>
<li>Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.</li>
<li>Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.</li>
</ul>
First Quarter 2024 Financial Results
Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.
Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prngen8" colspan="1" rowspan="1">
____________________________
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 2 Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.
</td>
</tr>
</table>
</div>
Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.
Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.
Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.
As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.
Conference Call
The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.
Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing ir@schwazze.com.
Date: Wednesday, May 15, 2024 Time: 5:00 p.m. Eastern time Toll-free dial-in: (888) 664-6383 International dial-in: (416) 764-8650 Conference ID: 84167910 Webcast: SHWZ Q1 2024 Earnings Call
The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.
Toll-free replay number: (888) 390-0541 International replay number: (416) 764-8677 Replay ID: 167910
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
About Schwazze
Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.
Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.
Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.
Investor Relations Contact Sean Mansouri, CFA or Aaron D’Souza Elevate IR (720) 330-2829 ir@schwazze.com
MEDICINE MAN TECHNOLOGIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS For the Periods Ended March 31, 2024 and December 31, 2023 Expressed in U.S. Dollars
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen10" colspan="2" rowspan="1">
 March 31,
</td>
<td class="prngen11" colspan="1" rowspan="1"></td>
<td class="prngen10" colspan="2" rowspan="1">
December 31, 
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen12" colspan="2" rowspan="1">
2024
</td>
<td class="prngen11" colspan="1" rowspan="1"></td>
<td class="prngen12" colspan="2" rowspan="1">
2023
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1"> 
ASSETS
 </td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Current Assets
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Cash & Cash Equivalents
</td>
<td class="prngen11" colspan="1" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" rowspan="1">
13,151,317
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" rowspan="1">
19,248,932
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Accounts Receivable, net of Allowance for Doubtful Accounts
</td>
<td class="prngen15" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
3,356,032
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen15" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
4,261,159
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Inventory
</td>
<td class="prngen16" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
26,382,184
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen16" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
25,787,793
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively
</td>
<td class="prngen16" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
108,583
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen16" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
456,099
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Prepaid Expenses & Other Current Assets
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
3,502,310
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
3,914,064
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Current Assets
</td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
46,500,426
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
53,668,047
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Non-Current Assets
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
31,326,000
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
31,113,630
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Investments
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
2,000,000
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
2,000,000
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Investments Held for Sale
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
–
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
202,111
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Goodwill
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
67,492,705
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
67,499,199
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
162,391,482
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
166,167,877
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Other Non-Current Assets
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,328,187
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,263,837
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Operating Lease Right of Use Assets
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
34,575,832
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
34,233,142
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Deferred Tax Assets, net
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
992,144
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,996,489
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Non-Current Assets
</td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
300,106,350
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
304,476,285
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Assets
</td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" rowspan="1">
346,606,776
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" rowspan="1">
358,144,332
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1"> 
LIABILITIES & STOCKHOLDERS’ EQUITY
 </td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Current Liabilities
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Accounts Payable
</td>
<td class="prngen11" colspan="1" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" rowspan="1">
9,443,233
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" rowspan="1">
13,341,561
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Accrued Expenses
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
8,106,618
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
7,774,691
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Derivative Liabilities
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,319,845
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
638,020
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Lease Liabilities – Current
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
5,186,316
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
4,922,724
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Current Portion of Long Term Debt
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
29,579,713
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
3,547,011
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Income Taxes Payable
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
28,235,039
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
25,232,782
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Current Liabilities
</td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
81,870,764
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
55,456,789
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Non-Current Liabilities
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Long Term Debt, net of Debt Discount & Issuance Costs
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
130,120,753
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
153,262,203
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Lease Liabilities – Non-Current
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
30,735,072
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
30,133,452
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Non-Current Liabilities
</td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
160,855,825
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
183,395,655
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Liabilities
</td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" rowspan="1">
242,726,589
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" rowspan="1">
238,852,444
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Stockholders’ Equity
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
December 31, 2023.
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
82
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
86
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
and 73,968,242 Shares Outstanding as of December 31, 2023.
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
79,169
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
74,888
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Additional Paid-In Capital
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
202,677,665
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
202,040,968
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Accumulated Deficit
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(96,843,602)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(80,790,927)
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
920,150 Shares Held as of December 31, 2023.
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(2,033,127)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(2,033,127)
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Stockholders’ Equity
</td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
103,880,187
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen18" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
119,291,888
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" rowspan="1">
Total Liabilities & Stockholders’ Equity
</td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" rowspan="1">
346,606,776
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" rowspan="1">
358,144,332
</td>
</tr>
</table>
</div>
MEDICINE MAN TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS) For the Periods Ended March 31, 2024 and 2023 Expressed in U.S. Dollars
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen10" colspan="5" rowspan="1">
For the Three Months Ended
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen22" colspan="5" rowspan="1">
March 31,
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen23" colspan="2" rowspan="1">
2024
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen23" colspan="2" rowspan="1">
2023
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen24" colspan="2" rowspan="1">
(Unaudited)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen10" colspan="2" rowspan="1">
(Unaudited)
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Operating Revenues
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Retail
</td>
<td class="prngen11" colspan="1" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" rowspan="1">
37,633,252
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" rowspan="1">
35,820,111
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Wholesale
</td>
<td class="prngen15" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
3,898,320
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen15" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
4,058,925
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Other
</td>
<td class="prngen15" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
69,421
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen15" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
121,900
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Total Revenue
</td>
<td class="prngen25" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
41,600,993
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen25" colspan="1" rowspan="1"></td>
<td class="prngen19" colspan="1" rowspan="1">
40,000,936
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Total Cost of Goods & Services
</td>
<td class="prngen16" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
23,667,319
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen16" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
18,152,163
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Gross Profit
</td>
<td class="prngen26" colspan="1" rowspan="1"></td>
<td class="prngen27" colspan="1" rowspan="1">
17,933,674
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen26" colspan="1" rowspan="1"></td>
<td class="prngen27" colspan="1" rowspan="1">
21,848,773
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Operating Expenses
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Selling, General and Administrative Expenses
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
11,835,818
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
10,100,934
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Professional Services
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,671,881
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,187,364
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Salaries
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
6,880,988
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
4,695,971
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Stock Based Compensation
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
253,916
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
214,544
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Total Operating Expenses
</td>
<td class="prngen28" colspan="1" rowspan="1"></td>
<td class="prngen27" colspan="1" rowspan="1">
20,642,603
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen28" colspan="1" rowspan="1"></td>
<td class="prngen27" colspan="1" rowspan="1">
16,198,813
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Income from Operations
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(2,708,929)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
5,649,960
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Other Income (Expense)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Interest Expense, net
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(8,307,369)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(7,745,854)
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Unrealized Gain (Loss) on Derivative Liabilities
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(681,825)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
8,501,685
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Other Loss
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
10,500
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
–
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Loss on Investment
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(33,382)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
–
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Unrealized Gain on Investment
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(347,516)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen11" colspan="1" rowspan="1">
1,816
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Total Other Income (Expense)
</td>
<td class="prngen28" colspan="1" rowspan="1"></td>
<td class="prngen29" colspan="1" rowspan="1">
(9,359,592)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen28" colspan="1" rowspan="1"></td>
<td class="prngen27" colspan="1" rowspan="1">
757,647
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Pre-Tax Net Income (Loss)
</td>
<td class="prngen30" colspan="1" rowspan="1"></td>
<td class="prnpr2 prnpl2 prnvab prntar prnsbtb1 prnrbrb1 prnbbbs prnsblb1" colspan="1" rowspan="1">
(12,068,521)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen30" colspan="1" rowspan="1"></td>
<td class="prngen32" colspan="1" rowspan="1">
6,407,607
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Provision for Income Taxes
</td>
<td class="prngen30" colspan="1" rowspan="1"></td>
<td class="prngen32" colspan="1" rowspan="1">
3,984,154
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen30" colspan="1" rowspan="1"></td>
<td class="prngen32" colspan="1" rowspan="1">
4,662,178
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Net Income (Loss)
</td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen34" colspan="1" rowspan="1">
(16,052,675)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen33" colspan="1" rowspan="1">
1,745,429
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Less: Accumulated Preferred Stock Dividends for the Period
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(2,155,259)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen21" colspan="1" rowspan="1">
(2,029,394)
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" rowspan="1">
Net Income (Loss) Attributable to Common Stockholders
</td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen35" colspan="1" rowspan="1">
(18,207,934)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen20" colspan="1" rowspan="1">
$
</td>
<td class="prngen35" colspan="1" rowspan="1">
(283,965)
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Earnings (Loss) per Share Attributable to Common Stockholders
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Basic Earnings (Loss) per Share
</td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen34" colspan="1" rowspan="1">
(0.24)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen34" colspan="1" rowspan="1">
(0.01)
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Diluted Earnings (Loss) per Share
</td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen34" colspan="1" rowspan="1">
(0.24)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen34" colspan="1" rowspan="1">
(0.06)
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen9" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Weighted Average Number of Shares Outstanding – Basic
</td>
<td class="prngen36" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
76,006,932
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen36" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
55,835,501
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Weighted Average Number of Shares Outstanding – Diluted
</td>
<td class="prngen36" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
76,006,932
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen36" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
101,608,278
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Comprehensive Income (Loss)
</td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen34" colspan="1" rowspan="1">
(16,052,675)
</td>
<td class="prngen9" colspan="1" rowspan="1"></td>
<td class="prngen33" colspan="1" rowspan="1">
$
</td>
<td class="prngen33" colspan="1" rowspan="1">
1,745,429
</td>
</tr>
</table>
</div>
MEDICINE MAN TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS For the Periods Ended March 31, 2024 and 2023 Expressed in U.S. Dollars
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen10" colspan="5" nowrap="nowrap" rowspan="1">
For the Three Months Ended
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen22" colspan="5" nowrap="nowrap" rowspan="1">
March 31,
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen23" colspan="2" nowrap="nowrap" rowspan="1">
2024
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen23" colspan="2" nowrap="nowrap" rowspan="1">
2023
</td>
</tr>
<tr>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen24" colspan="2" nowrap="nowrap" rowspan="1">
(Unaudited)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen10" colspan="2" nowrap="nowrap" rowspan="1">
(Unaudited)
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Cash Flows from Operating Activities:
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
Net Income (Loss) for the Period
</td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
$
</td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(16,052,675)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
1,745,429
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Depreciation & Amortization
</td>
<td class="prngen15" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
5,096,314
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen15" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
6,151,395
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Non-Cash Interest Expense
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
1,031,431
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
991,184
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Non-Cash Lease Expense
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
2,871,226
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
2,251,459
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Deferred Taxes
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
1,004,345
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(637,225)
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Loss on Investment
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
202,111
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
–
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Change in Derivative Liabilities
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
681,825
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(8,501,685)
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Amortization of Debt Issuance Costs
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
421,512
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
421,513
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Amortization of Debt Discount
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
2,303,246
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
1,999,933
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
(Gain) Loss on Investments, net
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
347,516
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(1,816)
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Stock Based Compensation
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
640,974
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
214,544
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Changes in Operating Assets & Liabilities (net of Acquired Amounts):
</td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Accounts Receivable
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
905,127
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(118,181)
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Inventory
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(587,900)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(3,023,251)
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Prepaid Expenses & Other Current Assets
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
411,754
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(3,036,801)
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Other Assets
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(64,350)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
360,674
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Change in Operating Lease Liabilities
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(2,348,703)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(1,531,765)
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Accounts Payable & Other Liabilities
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(3,566,401)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(3,464,671)
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Income Taxes Payable
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
3,002,257
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
5,299,403
</td>
</tr>
<tr>
<td class="prngen17" colspan="1" nowrap="nowrap" rowspan="1">
Net Cash Provided by (Used in) Operating Activities
</td>
<td class="prngen28" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen29" colspan="1" nowrap="nowrap" rowspan="1">
(3,700,390)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen28" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen29" colspan="1" nowrap="nowrap" rowspan="1">
(879,861)
</td>
</tr>
<tr>
<td class="prngen15" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen37" colspan="1" nowrap="nowrap" rowspan="1">
Cash Flows from Investing Activities:
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
Collection of Notes Receivable
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
–
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
10,631
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
Purchase of Fixed Assets
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(1,532,287)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(2,913,394)
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Net Cash Provided by (Used in) Investing Activities
</td>
<td class="prngen28" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen29" colspan="1" nowrap="nowrap" rowspan="1">
(1,532,287)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen28" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen29" colspan="1" nowrap="nowrap" rowspan="1">
(2,902,763)
</td>
</tr>
<tr>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen37" colspan="1" nowrap="nowrap" rowspan="1">
Cash Flows from Financing Activities:
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
Payment on Notes Payable
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(864,938)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
–
</td>
</tr>
<tr>
<td class="prngen14" colspan="1" nowrap="nowrap" rowspan="1">
Net Cash Provided by (Used in) Financing Activities
</td>
<td class="prngen28" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen29" colspan="1" nowrap="nowrap" rowspan="1">
(864,938)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen28" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen27" colspan="1" nowrap="nowrap" rowspan="1">
–
</td>
</tr>
<tr>
<td class="prngen16" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen37" colspan="1" nowrap="nowrap" rowspan="1">
Net (Decrease) in Cash & Cash Equivalents
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(6,097,615)
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen21" colspan="1" nowrap="nowrap" rowspan="1">
(3,782,624)
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" nowrap="nowrap" rowspan="1">
Cash & Cash Equivalents at Beginning of Period
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
19,248,932
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
38,949,253
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Cash & Cash Equivalents at End of Period
</td>
<td class="prngen20" colspan="1" nowrap="nowrap" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" nowrap="nowrap" rowspan="1">
13,151,317
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen20" colspan="1" nowrap="nowrap" rowspan="1">
$
</td>
<td class="prngen20" colspan="1" nowrap="nowrap" rowspan="1">
35,166,628
</td>
</tr>
<tr>
<td class="prngen15" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen8" colspan="1" nowrap="nowrap" rowspan="1">
Supplemental Disclosure of Cash Flow Information:
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
</tr>
<tr>
<td class="prngen13" colspan="1" nowrap="nowrap" rowspan="1">
Cash Paid for Interest
</td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
4,515,205
</td>
<td class="prngen9" colspan="1" nowrap="nowrap" rowspan="1"></td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
$
</td>
<td class="prngen11" colspan="1" nowrap="nowrap" rowspan="1">
6,540,748
</td>
</tr>
</table>
</div>
MEDICINE MAN TECHNOLOGIES, INC. ADJUSTED EBITDA RECONCILIATION (NON-GAAP) For the Periods Ended March 31, 2024 and 2023 Expressed in U.S. Dollars
<div>
<table border="0" cellpadding="1" cellspacing="0" class="prnbcc">
<tr>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen10" colspan="5" rowspan="1">
For the Three Months Ended
</td>
</tr>
<tr>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen22" colspan="5" rowspan="1">
March 31,
</td>
</tr>
<tr>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen39" colspan="2" rowspan="1">
2024
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen39" colspan="2" rowspan="1">
2023
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Net Income (Loss)
</td>
<td class="prngen40" colspan="1" rowspan="1">
$
</td>
<td class="prngen41" colspan="1" rowspan="1">
(16,052,675)
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
$
</td>
<td class="prngen40" colspan="1" rowspan="1">
1,745,429
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Interest Expense, net
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
8,307,369
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
7,745,854
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Provision for Income Taxes
</td>
<td class="prngen42" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
3,984,154
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen42" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
4,662,178
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Other (Income) Expense, net of Interest Expense
</td>
<td class="prngen42" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
1,052,223
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen42" colspan="1" rowspan="1"></td>
<td class="prngen41" colspan="1" rowspan="1">
(8,503,501)
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Depreciation & Amortization
</td>
<td class="prngen43" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
5,618,834
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen43" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
6,612,814
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Earnings Before Interest, Taxes, Depreciation and
</td>
<td class="prngen44" colspan="1" rowspan="1"></td>
<td class="prngen45" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen44" colspan="1" rowspan="1"></td>
<td class="prngen45" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Amortization (EBITDA) (non-GAAP)
</td>
<td class="prngen46" colspan="1" rowspan="1">
$
</td>
<td class="prngen46" colspan="1" rowspan="1">
2,909,905
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen46" colspan="1" rowspan="1">
$
</td>
<td class="prngen46" colspan="1" rowspan="1">
12,262,774
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Non-Cash Stock Compensation
</td>
<td class="prngen43" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
253,916
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen43" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
214,544
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Deal Related Expenses
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
637,761
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
1,195,802
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Capital Raise Related Expenses
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
20,760
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
35,068
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Severance
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
484,561
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
118,436
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Retention Program Expenses
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
807,500
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
280,632
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Pre-Operating & Dark Carry Expenses
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
1,053,837
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
391,917
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
One-Time Legal Settlements
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
417,653
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
–
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Other Non-Recurring Items
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
754,751
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
25,707
</td>
</tr>
<tr>
<td class="prngen37" colspan="1" rowspan="1">
Adjusted EBITDA (non-GAAP)
</td>
<td class="prngen47" colspan="1" rowspan="1">
$
</td>
<td class="prngen47" colspan="1" rowspan="1">
7,340,644
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen47" colspan="1" rowspan="1">
$
</td>
<td class="prngen47" colspan="1" rowspan="1">
14,524,880
</td>
</tr>
<tr>
<td class="prngen8" colspan="1" rowspan="1">
Revenue
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
41,600,993
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen40" colspan="1" rowspan="1">
40,000,936
</td>
</tr>
<tr>
<td class="prngen13" colspan="1" rowspan="1">
Adjusted EBITDA Percent
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td align="right" class="prngen21" colspan="1" rowspan="1">
17.6 %
</td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td class="prngen38" colspan="1" rowspan="1"></td>
<td align="right" class="prngen21" colspan="1" rowspan="1">
36.3 %
</td>
</tr>
</table>
</div>
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=TO15533&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146823.html
SOURCE Schwazze
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=TO15533&Transmission_Id=202405151605PR_NEWS_USPR_____TO15533&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/schwazze-announces-first-quarter-2024-financial-results/9045/">Schwazze Announces First Quarter 2024 Financial Results</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>IBM Expands Qiskit, World’s Most Performant Quantum Software</title>
<link>https://bubblear.com/ibm-expands-qiskit-worlds-most-performant-quantum-software/9042/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 19:30:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/ibm-expands-qiskit-worlds-most-performant-quantum-software/9042/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="480" height="360" src="https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software.jpg 480w, https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software-300x225.jpg 300w, https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software-86x64.jpg 86w" sizes="(max-width: 480px) 100vw, 480px" /></div>Qiskit now refined as a comprehensive quantum software stack, focused on performance and stability to fully harness the power of utility-scale quantum hardware, and enable users to run increasingly more complex quantum circuits in the search for quantum advantage. YORKTOWN HEIGHTS, N.Y., May 15, 2024 /PRNewswire/ — IBM (NYSE: IBM) today announced the evolution and expansion of Qiskit, […]
The post <a rel="nofollow" href="https://bubblear.com/ibm-expands-qiskit-worlds-most-performant-quantum-software/9042/">IBM Expands Qiskit, World’s Most Performant Quantum Software</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="480" height="360" src="https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software.jpg 480w, https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software-300x225.jpg 300w, https://bubblear.com/wp-content/uploads/2024/05/ibm-expands-qiskit-worlds-most-performant-quantum-software-86x64.jpg 86w" sizes="(max-width: 480px) 100vw, 480px" /></div>
<ul type="disc">
<li>Qiskit now refined as a comprehensive quantum software stack, focused on performance and stability to fully harness the power of utility-scale quantum hardware, and enable users to run increasingly more complex quantum circuits in the search for quantum advantage. </li>
</ul>
YORKTOWN HEIGHTS, N.Y., May 15, 2024 /PRNewswire/ — IBM (NYSE: IBM) today announced the evolution and expansion of Qiskit, its globally adopted quantum software. Launched in 2017, Qiskit, as a software development kit (SDK) is an open-source tool that has allowed over 550,000 users to build and run quantum circuits on IBM’s quantum hardware systems, resulting in the execution of over 3 trillion quantum circuits to date.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
<iframe loading="lazy" frameborder="0" height="315" src="https://www.youtube.com/embed/I8Tw_ptO9DI" width="560"> </iframe>
</div>
The latest version of Qiskit has been expanded to a comprehensive software stack to deliver even more performance. It has evolved from its beginnings as a popular quantum software development kit used to explore and run quantum computing experiments and into a stable SDK and portfolio of services, built to enable users to extract improved performance while running complex quantum circuits on 100+ qubit IBM quantum computers.
This expansion will equip members of the IBM Quantum Network with the most performant Qiskit capabilities available to discover the next generation of quantum algorithms in their respective domains: which will play an important role in their discovery of quantum advantage.
To reach quantum advantage, users need a toolset which can map their problems in a way which leverages both advanced classical and quantum computation; optimizes the problem for efficient execution with quantum; and then effectively executes the quantum circuits on real quantum hardware. IBM has spent the last seven years developing these tools, which are now coming together to comprise the Qiskit software stack.
This expansion of Qiskit includes over 100 releases from its origins as a pioneering research tool built to study the inner workings of quantum computers. Today, Qiskit has matured as a software stack on which enterprises, government organizations, research institutions, and universities are running large-scale quantum experiments.
The expanded software stack of Qiskit includes:
<ul type="disc">
<li>The stable release of Qiskit SDK v1.x for building, optimizing, and visualizing quantum circuits.</li>
<li>AI-powered optimization of quantum circuits for quantum hardware, embedded in the Qiskit Transpiler Service. </li>
<li>Simplified execution modes for the Qiskit Runtime Service which can be tailored for performant execution of quantum circuits on quantum hardware.</li>
<li>The Qiskit Code Assistant, powered by watsonx-based generative AI models, to automate the development of quantum code</li>
<li>The Qiskit Serverless open-source tool to run quantum-centric supercomputing workloads across quantum hardware and classical clusters.</li>
</ul>
The deployment of new capabilities and improvements within Qiskit SDK are enabling users to optimize circuits for quantum hardware at a rate 39 times faster than Qiskit 0.331. Qiskit also is engineered to reduce the overhead and shrink the footprint of circuits, demonstrating an average of 3 times reduction in memory usage compared to Qiskit 0.43.2
And using the Qiskit Transpiler Service, users can reduce circuit depth by combining AI and heuristic passes, compared to using the Qiskit SDK without AI optimization.
“The global adoption of quantum computing — and the discovery of quantum advantage — will require a combination of leading quantum hardware alongside a robust and performant software stack to run workloads,” said Jay Gambetta, IBM Fellow and Vice President, IBM Quantum. “These two pillars are fundamental to the algorithm discovery that has begun on utility-scale quantum hardware. As a growing quantum ecosystem maps their most difficult problems to quantum circuits, the Qiskit stack will be the cornerstone to exploring the computational spaces in which quantum computing excels.”
IBM first demonstrated the utility-scale capabilities of its quantum hardware in 2023. This signaled the start of an era in which quantum hardware can run quantum circuits faster and more accurately than a classical computer simulating a quantum computer can. Now built to maximize the performance of advanced quantum hardware, the Qiskit software stack aims to help a global ecosystem of users discover new quantum algorithms that explore where quantum computers could be the best way to solve challenges over any classical method.
“Qiskit provides an important collection of tools for E.ON as we explore how quantum computing could help us navigate the financial and operational complexities of the energy industry,” said Giorgio Cortiana, Head of Data and AI – Energy Intelligence, E.ON. “As a performant foundation to build and discover quantum algorithms that can be applied to business use cases, Qiskit enables our team to advance utility-scale prototypes, with the goal of finding new solutions to challenges in the European energy sector.”
“We started using Qiskit for our quantum computing efforts several years ago as part of an effort to help develop a quantum-ready workforce,” said Stephan Eidenbenz, senior scientist at Los Alamos National Laboratory. “Laboratory researchers use Qiskit daily to interact with IBM’s quantum hardware backends and to test new algorithmic ideas. The open nature of Qiskit also offers our team the ability to add compiler optimization passes and allows pulse-level access.”
“At Brookhaven, we have used Qiskit to execute circuits on IBM’s quantum hardware, which has resulted in almost 20 published papers to date, including exploring the frontiers of physics, dynamic systems, condensed matter systems, and more. Qiskit has also enabled our teams to develop extensions that push forward our exploration of bosonic and hybrid qubit-bosonic circuits, and how they could advance fundamental quantum algorithm development and error correction,” said James Misewich, Associate Laboratory Director for Energy and Photon Sciences, Brookhaven National Laboratory. “As we advance the scientific applications of quantum computing, we have incorporated IBM’s Qiskit resources and tutorials into our educational programs through Brookhaven’s Co-design Center for Quantum Advantage, where we partner with academic institutions like Stony Brook University to prepare the quantum workforce of the future.”
“For our Quantum Computing User Program here at Oak Ridge National Laboratory, advances in quantum computing software can help support the innovation and rapid growth of our user community and their developing technologies,” said Travis Humble, director of the Department of Energy’s Quantum Science Center at Oak Ridge National Laboratory. “Improvements in software performance will significantly impact how users test and evaluate the potential of today’s quantum computing systems.”
“The team at Q-CTRL is enthusiastic about building with Qiskit,” said Michael J. Biercuk, CEO and Founder of Q-CTRL. “Its flexible new interfaces and enhanced stability are enabling us to efficiently build simple abstractions on top of our powerful performance-management software at utility scale, so end users can explore their toughest problems with a single command.”
Built for the Era of Quantum Utility and Beyond 
Through its support of rapidly advancing quantum hardware, including vendor-agnostic flexibility, the Qiskit software stack is designed to run the breakthrough quantum circuits to progress the era of quantum utility. This is achieved by replacing performance-critical code with the Rust programming language, alongside a full portfolio of tools to enable the efficient execution of quantum circuits.
As IBM continues to build milestones along its IBM Quantum Development and Innovation Roadmap towards error-corrected systems, the company expects that Qiskit will continue to deliver a framework for open, iterative, and collaborative development of new quantum algorithms and applications, done in conjunction with a growing global ecosystem of clients across industries and domain expertise areas.
Additionally, these advancing capabilities will aim to help users weave together classical and quantum computing resources into a new paradigm of high-performance computing defined by quantum-centric supercomputing that integrates QPUs, GPUs, and CPUs. Orchestrated through the performant software layer of Qiskit, this next evolution of high-performance computing aims to open up new, large, and powerful spaces for industries globally.
<ol type="1">
<li>Disclaimer: IBM’s statements regarding Qiskit’s performance compares the current iteration of the software against its performance from applicable previous version when comparable features were available to users. Qiskit 0.33 total speed time equaled 430.89 seconds at IBM Quantum Summit 2021. Qiskit 1.0 total speed time equaled 10.9 seconds upon release in February, 2024.</li>
<li>Disclaimer: IBM’s statements regarding Qiskit’s performance compares the current iteration of the software against its performance from applicable previous version when comparable features were available to users. Qiskit 0.43 memory usage equaled 1,750 MiB in May, 2023. Qiskit 1.0 memory usage equaled 580 MiB upon release in February, 2024.</li>
</ol>
IBM’s statements regarding its plans, directions, and intent are subject to change or withdrawal without notice at IBM’s sole discretion. The development, release, and timing of any future features or functionality described for our products remain at our sole discretion.
About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, responsibility, inclusivity and service.
MEDIA CONTACTS
Erin Angelini IBM Communications edlehr@us.ibm.com 
Chris Nay IBM Communicaitons cnay@us.ibm.com
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <img decoding="async" alt="" src="https://mma.prnewswire.com/media/2413995/IBM_Leadspace_Qiskit_social.jpg" title=""></img> 
 <img decoding="async" alt="IBM Corporation logo. (PRNewsfoto/IBM)" src="https://mma.prnewswire.com/media/95470/ibm_logo.jpg" title="IBM Corporation logo. (PRNewsfoto/IBM)"></img> 
</div>
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=NY14485&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/ibm-expands-qiskit-worlds-most-performant-quantum-software-302146837.html
SOURCE IBM
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY14485&Transmission_Id=202405151530PR_NEWS_USPR_____NY14485&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/ibm-expands-qiskit-worlds-most-performant-quantum-software/9042/">IBM Expands Qiskit, World’s Most Performant Quantum Software</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>Preserving the historical Québec Bridge for future generations</title>
<link>https://bubblear.com/preserving-the-historical-quebec-bridge-for-future-generations/9039/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 14:14:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/preserving-the-historical-quebec-bridge-for-future-generations/9039/</guid>
<description><![CDATA[QUEBEC CITY, May 15, 2024 /CNW/ – For over 100 years, the Québec Bridge has stood as a testament to the innovation and hard work of Canadians, linking communities and businesses on both sides of the St. Lawrence River. In recent years, the Government of Canada has been working to identify the best path forward […]
The post <a rel="nofollow" href="https://bubblear.com/preserving-the-historical-quebec-bridge-for-future-generations/9039/">Preserving the historical Québec Bridge for future generations</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[
QUEBEC CITY, May 15, 2024 /CNW/ – For over 100 years, the Québec Bridge has stood as a testament to the innovation and hard work of Canadians, linking communities and businesses on both sides of the St. Lawrence River. In recent years, the Government of Canada has been working to identify the best path forward to ensure the bridge’s long-term sustainability, and today we are taking an important step toward that goal.
The Prime Minister, Justin Trudeau, today announced an agreement with the Canadian National Railway (CN), the current owner of the Québec Bridge, to repatriate this essential and historic infrastructure to the federal government and support its long-term viability. Canada will invest approximately $40 million per year for the next 25 years through its rehabilitation program. These investments will help extend the bridge’s useful life for decades to come, notably by increasing the frequency at which parts are replaced. The rehabilitation program also includes a contribution component for painting and aesthetics of this historic infrastructure.
The Québec Bridge is a major road, rail, and pedestrian bridge linking the shores of Quebec City and Lévis, Quebec. Built in 1917, it was designed to boost economic development and connect Quebec City to the Canadian and American rail networks. Considered one of Canada’s architectural gems, it is recognized as a symbol of engineering excellence and was designated a National Historic Site of Canada in 1995.
Today, the bridge remains a critical regional transportation link, a strategic freight corridor, and an important element of the Canadian supply chain, allowing passengers and goods to move freely across the St. Lawrence River and to other destinations in Canada and North America. More than 33,000 vehicles, including cars, transit buses, passenger trains, and freight trains, cross the bridge daily. During the summer months, it is also enjoyed by some 1,000 pedestrians and cyclists every day.
The repatriation agreement is the result of significant consultations and negotiations with CN, the Government of Quebec, and other stakeholders. The agreement will position the federal government to restore and maintain the structure of the Québec Bridge to ensure it can continue to benefit our economy and all users and residents of Greater Québec – preserving the bridge’s historical, cultural, and economic value for future generations.
<div aria-level="3" class="wcag-arialevel-3" role="heading" style="display: block; font-size: 1.17em; margin-block-start: 1em; margin-block-end: 1em; margin-inline-start: 0px; margin-inline-end: 0px; font-weight: bold; text-align: left;">Quotes</div>
“The Québec Bridge is a source of pride for the people of Quebec City and all Canadians. It is a timeless symbol of what is possible when we work hard together, and today’s repatriation agreement with CN will ensure that it is protected and restored for future generations.”
— The Rt. Hon. Justin Trudeau, Prime Minister of Canada
“The Québec Bridge is a feat of civil and architectural engineering in our country. By repatriating the bridge, we will not only ensure the sustainability of this critical and major infrastructure for the region, but we are also giving control back to the people of Québec.”
— The Hon. Jean-Yves Duclos, Minister of Public Services and Procurement
“The Québec Bridge is part of the city’s history. It’s part of the identity and pride of the people of Quebec City. By repatriating this essential link, we are fortifying and preserving both our heritage and our future prosperity.”
— The Hon. Pablo Rodriguez, Minister of Transport and Quebec Lieutenant
<div aria-level="3" class="wcag-arialevel-3" role="heading" style="display: block; font-size: 1.17em; margin-block-start: 1em; margin-block-end: 1em; margin-inline-start: 0px; margin-inline-end: 0px; font-weight: bold; text-align: left;">Quick Facts</div>
<ul type="disc">
<li>The Québec Bridge was designed and built by the St. Lawrence Bridge Company of Montréal, Quebec, in 1917. Made of nickel alloy steel, it was the longest clear span bridge in the world at the time of its construction. It was officially inaugurated by the Prince of Wales – the future King Edward VIII – in 1919.</li>
<li>Initially designed as a rail bridge, the Québec Bridge now also includes three highway lanes and a walkway for pedestrians and cyclists. It remains the longest span cantilever bridge ever built, stretching 549 metres between the main piers, with a total length of 987 metres and a height of 95 metres.</li>
<li>The bridge was under ownership of the Government of Canada from its construction until 1995, when it was transferred to Canadian National Railway (CN).</li>
<li>In 2019, the Government of Canada appointed Mr. Yvon Charest as Special Negotiator to examine options for the bridge’s restoration and life extension. Following extensive consultations with CN and other stakeholders, the government received Mr. Charest’s recommendations in 2021 and extended his mandate for the negotiation of an agreement to transfer ownership of the bridge to the federal government.</li>
</ul>
<div aria-level="3" class="wcag-arialevel-3" role="heading" style="display: block; font-size: 1.17em; margin-block-start: 1em; margin-block-end: 1em; margin-inline-start: 0px; margin-inline-end: 0px; font-weight: bold; text-align: left;">Related Products</div>
<ul type="disc">
<li>Did you know that? The Québec Bridge by numbers</li>
<li>Backgrounder: Preserving the historical Québec Bridge for future generations</li>
</ul>
<div aria-level="3" class="wcag-arialevel-3" role="heading" style="display: block; font-size: 1.17em; margin-block-start: 1em; margin-block-end: 1em; margin-inline-start: 0px; margin-inline-end: 0px; font-weight: bold; text-align: left;">Associated Links</div>
<ul type="disc">
<li>The Government of Canada announces a major step in the restoration of the Québec Bridge</li>
<li>The history of the Québec Bridge</li>
<li>Québec Bridge National Historic Site of Canada</li>
</ul>
This document is also available at https://pm.gc.ca
SOURCE Prime Minister’s Office
<img decoding="async" alt="" src="https://rt.newswire.ca/rt.gif?NewsItemId=C6583&Transmission_Id=202405151014CANADANWCANADAPR_C6583&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/preserving-the-historical-quebec-bridge-for-future-generations/9039/">Preserving the historical Québec Bridge for future generations</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>Socure Unveils “The State of Digital Identity in 2024” Report for State Government Agency and Technology Leaders</title>
<link>https://bubblear.com/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders/9037/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 14:14:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders/9037/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="55" src="https://bubblear.com/wp-content/uploads/2024/05/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>New research uncovers biggest identity-related challenges facing state governments and provides recommendations for delivering a frictionless constituent experience INCLINE VILLAGE, Nev., May 15, 2024 /PRNewswire/ — Socure, the leading provider of artificial intelligence for digital identity verification, sanctions screening, and fraud prevention, today released a new report titled, “The State of Digital Identity in 2024″, in […]
The post <a rel="nofollow" href="https://bubblear.com/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders/9037/">Socure Unveils “The State of Digital Identity in 2024” Report for State Government Agency and Technology Leaders</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="55" src="https://bubblear.com/wp-content/uploads/2024/05/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
New research uncovers biggest identity-related challenges facing state governments and provides recommendations for delivering a frictionless constituent experience
INCLINE VILLAGE, Nev., May 15, 2024 /PRNewswire/ — Socure, the leading provider of artificial intelligence for digital identity verification, sanctions screening, and fraud prevention, today released a new report titled, “The State of Digital Identity in 2024″, in partnership with The Center for Digital Government.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Socure's logo (PRNewsfoto/Socure)" src="https://mma.prnewswire.com/media/2203821/Primary_Logo_CMYK_TM_large_Logo.jpg" title="Socure's logo (PRNewsfoto/Socure)"></img> 
</div>
According to the Government Accountability Office, the federal government loses an estimated $233 billion to $521 billion to fraud annually. State agencies, tasked with distributing federal funds, face challenges when providing seamless digital identity verification for constituents while defending against sophisticated bad actors, including fraudsters, crime rings, and nation-state attacks. 
State agency leaders surveyed cited regulatory and policy challenges, privacy concerns, and the complexity of integrating digital identity verification solutions with legacy systems among the top identity-related pain points. The data also highlighted the need for state technology leaders to modernize digital identity verification systems to fight fraud and improve the constituent experience. According to the report, 63% of constituents surveyed want to conduct all or most transactions with state agencies online, yet only 13% felt very confident state agencies can detect and prevent identity fraud. And more than half of the state leaders surveyed said they rely on knowledge-based authentication as a method of verification, despite the National Institute of Standards and Technology no longer recognizing it as a valid method of verifying identities.
“State governments play a pivotal role in ensuring critical services reach the right people in an efficient and equitable manner,” said Matt Thompson, senior vice president and general manager of the public sector at Socure. “As fraud techniques evolve, state technology leaders will continue to face new challenges when verifying identity online. We are committed to providing our government partners with the resources, tools, and services needed to combat fraud and deliver a frictionless experience for their constituents.”
The report also includes best practices for creating a modern identity system with insight from industry experts including: 
<ul type="disc">
<li>Deploy a proactive, layered approach to prevent fraud: Apply a layered strategy with multiple verification techniques and authentication technologies for detecting anomalies and distinguishing between normal interactions and deliberate fraud attempts.</li>
<li>Put metrics and key performance indicators to work: Continuously measure to document and improve effectiveness and equity.</li>
<li>Fight friction using AI: Advancements in AI models and automation tools means strong identity verification no longer equates to poor user experience.</li>
</ul>
A case study from the Florida Department of Economic Opportunity (DEO) demonstrates how states can remove friction from identity verification and speed assistance to applicants. Using Socure’s platform that leverages advanced AI and machine learning (ML), the DEO saw 95 percent of applicants to Florida’s Homeowner Assistance Fund automatically approved in less than one second. The department also saw a 15-40 percent increase in customer approval rates compared to its previous identity verification providers. Automatic claim rejections have fallen below 1 percent.
The report is based on two national surveys that polled 2,008 constituents and 125 state government leaders on issues related to online identity verification and fraud prevention as well as qualitative interviews with technology leaders in 21 states.
To download the full report, click here.
About the Center for Digital Government The Center for Digital Government, a division of e.Republic, is a national research and advisory institute on information technology policies and best practices in state and local government. Through its diverse and dynamic programs and services, the Center provides public- and private-sector leaders with decision support, knowledge and opportunities to help them effectively incorporate new technologies in the 21st century.
About Socure Socure is the leading provider of digital identity verification and fraud solutions. Its predictive analytics platform applies AI and machine learning techniques with trusted online and offline data intelligence to verify identities in real-time. The company has more than 2,300 customers across the financial services, government, gaming, healthcare, telecom, and e-commerce industries, including four of the five top banks, the top credit bureau and more than 400 fintechs. Organizations including Capital One, Citi, Chime, SoFi, Green Dot, Varo, Ingo, Robinhood, Gusto, Public, Poshmark, Stash, DraftKings, PrizePicks and the State of California trust Socure for accurate and inclusive identity verification and fraud prevention. Learn more at socure.com.
 
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=LA15339&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders-302146444.html
SOURCE Socure
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA15339&Transmission_Id=202405151014PR_NEWS_USPR_____LA15339&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/socure-unveils-the-state-of-digital-identity-in-2024-report-for-state-government-agency-and-technology-leaders/9037/">Socure Unveils “The State of Digital Identity in 2024” Report for State Government Agency and Technology Leaders</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
<item>
<title>Introducing Coventry’s New ScrubaDub: Rhode Island’s Premier State-of-the-Art Car Wash</title>
<link>https://bubblear.com/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash/9040/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Wed, 15 May 2024 14:13:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://bubblear.com/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash/9040/</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="108" src="https://bubblear.com/wp-content/uploads/2024/05/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://bubblear.com/wp-content/uploads/2024/05/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash.jpg 144w, https://bubblear.com/wp-content/uploads/2024/05/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash-86x64.jpg 86w" sizes="(max-width: 144px) 100vw, 144px" /></div>COVENTRY, R.I., May 15, 2024 /PRNewswire/ — ScrubaDub, New England’s leading car wash company since 1966, is excited to announce the grand opening of their Coventry, RI location at 2305 New London Turnpike (next to Wendy’s). The newest facility features a cutting-edge, eco-friendly exterior car wash tunnel with innovative design and convenient flat conveyor belt […]
The post <a rel="nofollow" href="https://bubblear.com/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash/9040/">Introducing Coventry’s New ScrubaDub: Rhode Island’s Premier State-of-the-Art Car Wash</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="108" src="https://bubblear.com/wp-content/uploads/2024/05/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://bubblear.com/wp-content/uploads/2024/05/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash.jpg 144w, https://bubblear.com/wp-content/uploads/2024/05/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash-86x64.jpg 86w" sizes="(max-width: 144px) 100vw, 144px" /></div>
COVENTRY, R.I., May 15, 2024 /PRNewswire/ — ScrubaDub, New England’s leading car wash company since 1966, is excited to announce the grand opening of their Coventry, RI location at 2305 New London Turnpike (next to Wendy’s). The newest facility features a cutting-edge, eco-friendly exterior car wash tunnel with innovative design and convenient flat conveyor belt for easy vehicle loading. “As part of our commitment to customer satisfaction, every visitor enjoys ScrubaDub’s renowned complimentary offerings including pretzels, stickers for kids, dog treats, and access to our Satisfaction Center for those final finishing touches. All ScrubaDub services are backed by our 100% Satisfaction Guarantee,” said Mathew Paisner, Director of Business Development.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" alt="Coventry's New ScrubaDub: Rhode Island's Premier State-of-the-Art Car Wash" src="https://mma.prnewswire.com/media/2412824/ScrubaDub_Coventry.jpg" title="Coventry's New ScrubaDub: Rhode Island's Premier State-of-the-Art Car Wash"></img> 
</div>
Customers who join ScrubaDub’s Unlimited car wash membership can wash anytime they like across 20+ New England ScrubaDub locations and receive access to free self-service vacuums, mat cleaning, gas discounts, and more! For a limited time, new Coventry customers can join ScrubaDub Unlimited for only $5 for the first month!
ScrubaDub Coventry will celebrate its grand opening with giveaways and events including a Ribbon Cutting on May 17th hosted by the Central RI Chamber of Commerce. As well as a Customer Appreciation event on Saturday, July 13th 12pm-2pm with the WPRO-FM Radio Street Team, morning show host Bekah Berger, and free drinks from Del’s All Natural Lemonade.
“As a third-generation family business, we look forward to providing the Coventry, Rhode Island community with the highest quality car wash experience,” said Danny Paisner, President.
About ScrubaDub Auto Wash Family-owned and operated since 1966, ScrubaDub Auto Wash Centers is New England’s leading car wash company, ranking among the top auto wash chains in the USA. ScrubaDub offers all formats of car washing as well as detail centers, gasoline stations, and convenience stores. For more information, visit https://www.scrubadub.com/.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <img decoding="async" alt="(PRNewsfoto/ScrubaDub Auto Wash Centers)" src="https://mma.prnewswire.com/media/1474419/ScrubaDub_Auto_Wash_Centers__Logo.jpg" title="(PRNewsfoto/ScrubaDub Auto Wash Centers)"></img> 
</div>
<img loading="lazy" decoding="async" alt="Cision" height="12" src="https://c212.net/c/img/favicon.png?sn=NE14406&sd=2024-05-15" title="Cision" width="12"></img> View original content to download multimedia:https://www.prnewswire.com/news-releases/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash-302146050.html
SOURCE ScrubaDub Auto Wash Centers
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=NE14406&Transmission_Id=202405151013PR_NEWS_USPR_____NE14406&DateId=20240515" style="border:0px; width:1px; height:1px;"></img> Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Bubblear.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://bubblear.com/introducing-coventrys-new-scrubadub-rhode-islands-premier-state-of-the-art-car-wash/9040/">Introducing Coventry’s New ScrubaDub: Rhode Island’s Premier State-of-the-Art Car Wash</a> appeared first on <a rel="nofollow" href="https://bubblear.com">The Bubble</a>.
]]></content:encoded>
</item>
</channel>
</rss>

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

Download the "valid RSS" banner.
Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)
Add this HTML to your page (change the image src attribute if necessary):

<a href="http://www.feedvalidator.org/check.cgi?url=https%3A//bubblear.com/feed/"><img src="valid-rss-rogers.png" alt="[Valid RSS]" title="Validate my RSS feed" /></a>

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=https%3A//bubblear.com/feed/

Home · About · News · Docs · Terms